These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19727918)

  • 1. Cartilage oligomeric matrix protein/thrombospondin-5 (COMP/TSP-5) levels do not correlate to functional class in patients with rheumatoid arthritis.
    Andrade FD; Bender AL; da Silveira IG; Stein H; von Mühlen CA; Staub HL
    Clin Rheumatol; 2009 Dec; 28(12):1441-2. PubMed ID: 19727918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis.
    Bender AL; da Silveira IG; von Mühlen CA; Staub HL
    Clin Chem Lab Med; 2010 Apr; 48(4):569-70. PubMed ID: 20148721
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.
    Roux-Lombard P; Eberhardt K; Saxne T; Dayer JM; Wollheim FA
    Rheumatology (Oxford); 2001 May; 40(5):544-51. PubMed ID: 11371663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.
    Andersson ML; Svensson B; Petersson IF; Hafström I; Albertsson K; Forslind K; Heinegård D; Saxne T
    BMC Musculoskelet Disord; 2013 Aug; 14():229. PubMed ID: 23915292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments.
    Morozzi G; Fabbroni M; Bellisai F; Pucci G; Galeazzi M
    Ann N Y Acad Sci; 2007 Jun; 1108():398-407. PubMed ID: 17894003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap.
    Gheita TA; Hussein H
    Joint Bone Spine; 2012 Jan; 79(1):51-6. PubMed ID: 21497537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence of cartilaginous benefit of treatment with infliximab in rheumatoid arthritis using measurement of serum COMP].
    Yamamoto M; Takahashi H; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Shinomura Y; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Feb; 30(1):41-7. PubMed ID: 17332704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.
    de Jong Z; Munneke M; Vilim V; Zwinderman AH; Kroon HM; Ronday HK; Lems WF; Dijkmans BA; Breedveld FC; Vliet Vlieland TP; Hazes JM; Degroot J
    Rheumatology (Oxford); 2008 Jun; 47(6):868-71. PubMed ID: 18400837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional capacity and cartilage oligomeric protein (COMP) in serum of patients with maturity-onset polyarthritis].
    Kolarz G; Hermann J; Krajnc I; Palkonyai E; Scherak O; Schödl Ch; Singer F; Temesvari P; Wagner E; Wottawa A
    Z Rheumatol; 2002 Aug; 61(4):435-9. PubMed ID: 12426849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis.
    Forslind K; Eberhardt K; Jonsson A; Saxne T
    Br J Rheumatol; 1992 Sep; 31(9):593-8. PubMed ID: 1525624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
    Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
    Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
    Morozzi G; Fabbroni M; Bellisai F; Cucini S; Simpatico A; Galeazzi M
    Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab.
    Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
    Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
    Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.